CMS Halts Bidding For Competitive Drug Purchase Program, Pushes Start To July 2006
This article was originally published in The Pink Sheet Daily
Executive Summary
The Medicare agency says it needs more time to review public comments and make “clarifications” to its interim final rule for the Part B competitive acquisition program.
You may also be interested in...
US Oncology Pressing CMS For CAP Revisions, Though Not Submitting Bid
Delay in implementing the competitive acquisition program for Part B could lead to beneficial changes, the cancer services network states.
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.